This bill expands federal grant programs to increase expense reimbursements for living organ donors and mandates a study on potential Medicare coverage for donation-related costs.
Suzan DelBene
Representative
WA-1
The Expanding Support for Living Donors Act of 2026 strengthens the federal grant program that reimburses living organ donors for qualifying expenses by increasing eligibility and funding caps. The bill also mandates comprehensive annual reporting on program efficacy and requires a GAO study to explore how Medicare could further cover organ donation costs.
The Expanding Support for Living Donors Act of 2026 aims to make the selfless act of organ donation less of a financial gamble. By amending the Public Health Service Act, the bill significantly broadens the federal grant program that pays donors back for the out-of-pocket costs—like travel and lost wages—that often come with surgery. Starting in fiscal year 2027, the bill establishes a maximum reimbursement of $10,000 per donor, a number that will be adjusted annually for inflation. Crucially, it prevents grant recipients from turning away donors based on income if they earn up to 700% of the federal poverty line—which, for a family of four today, is over $200,000. This shift moves the program from a narrow safety net to a resource accessible to the vast majority of working Americans.
For a construction worker or a software developer considering a kidney donation, the biggest hurdle isn't just the surgery; it’s the weeks of unpaid recovery time and travel to specialized hospitals. Section 2 of the bill addresses this by setting that $10,000 reimbursement ceiling, ensuring that donors aren't stuck with a massive bill for saving a life. While $10,000 is the standard, the Secretary of Health and Human Services (HHS) does have a 'break glass in case of emergency' power: if the program runs low on funds, the Secretary can lower that cap for specific grant recipients. However, they have to give Congress a 30-day heads-up and a solid reason why, and it won't affect anyone whose reimbursement was already approved.
This isn't just about cutting checks; it’s about proving the program works. Beginning December 31, 2027, the government has to pull back the curtain with a massive annual report. This report will track everything from the types of organs donated to the specific demographics of who is applying. Most interestingly, Section 2 requires an estimate of how much money the program is saving Medicare. Since a transplant is often cheaper for the taxpayer in the long run than years of dialysis, the bill is looking to see if the math supports even more expansion. It also forces the government to look at the 'unmet need'—calculating exactly how much it would cost to reimburse every single living donor in the country without any income caps at all.
Section 3 of the bill tasks the Government Accountability Office (GAO) with a one-year deep dive into the Medicare system. The goal is to see if Medicare can use its existing authority to pick up these donation costs directly, rather than relying on a separate grant program. This could eventually streamline the process, making reimbursement as standard as the medical procedure itself. For the average person, this means the bill is moving toward a world where 'donating an organ' doesn't have to mean 'draining your savings account,' treating the financial health of the donor with the same seriousness as their physical recovery.